Editorial Board

David Galeano

Editor-in-Chief, Nuclear Science and Technology · 2026–present

Universidad Nacional de Colombia

Dr. David Galeano is a engineer, energy systems specialist with more than 18 years of experience in the electric power sector, innovation strategy, and regulatory analysis. He currently serves as Chief Editor of the Nuclear Science and Technology community at ScienceBank, bringing a multidisciplinary perspective that integrates nuclear engineering, data science, public policy, and energy economics to support rigorous scientific dissemination and evidence-based decision-making. Dr. Galeano holds a Ph.D. in Physics from the University of Antioquia, an M.Sc. in Statistics from the National University of Colombia, and a degree in Electrical Engineering, complemented by postgraduate training in project evaluation, machine learning, and nuclear security. His doctoral research focused on advanced quantum systems and topological properties of materials, while his professional work has centered on energy systems modeling, risk analysis, and strategic planning for complex infrastructure.  He has completed specialized nuclear training at the International Atomic Energy Agency (IAEA) and Instituto Balseiro in Argentina and is a Certified Nuclear Security Specialised Professional (CNSsP) from the World Institute for Nuclear Security (WINS). His technical interests span nuclear energy deployment, small modular reactors, radiation science, fuel cycles, and the integration of nuclear power into sustainable energy systems, particularly in emerging economies. Professionally, Dr. Galeano works at EPM, one of Latin America’s largest public utilities, where he has held roles in innovation, energy regulation, market analysis, and strategic business development. His work includes feasibility studies for advanced energy technologies, regulatory impact modeling, demand forecasting, and financial projections for large-scale energy investments. In academia, he teaches nuclear energy courses at the National University of Colombia and the University of Antioquia and coordinates postgraduate-level training programs, including a Nuclear Energy Diploma program. He is also actively involved in research groups on nuclear physics, atomic and molecular physics, and nuclear technologies, and has collaborated internationally on theoretical materials science and energy policy. Dr. Galeano is a prolific author of scientific articles, technical reports, and policy analyses on nuclear energy, electricity markets, and energy transition in Latin America. His publications include peer-reviewed journal papers, book chapters, and outreach works aimed at improving public understanding of nuclear science. His contributions emphasize the role of nuclear technology in climate mitigation, energy security, and sustainable development. Beyond academia and industry, he plays a leadership role in professional organizations, serving in engineering societies and nuclear advocacy initiatives that promote the responsible adoption of nuclear technologies in Colombia and the region. His work bridges technical research, institutional capacity building, and public engagement. As Chief Editor, Dr. Galeano is committed to fostering a high-quality, globally inclusive platform for multidisciplinary research that advances nuclear science and technology across power generation, medicine, industry, agriculture, and environmental protection.

• Physical sciences

Patricia D'Amore, PhD

Editor-in-Chief, Vascular Biology · 2026–present

Harvard Medical School

Dr. Patricia A. D’Amore, a distinguished angiogenesis researcher, has made significant strides in understanding the mechanisms and regulation of vascular growth. Earning her Ph.D. from Boston University in 1977, she later joined Johns Hopkins University and Boston Children’s Hospital, eventually becoming a professor in Ophthalmology and Pathology at Harvard Medical School. D'Amore’s seminal work includes contributing to the discovery of vascular endothelial growth factor (VEGF) as a crucial element in pathological blood vessel growth in eye diseases, which led to the development of anti-VEGF therapies for treating cancers and eye conditions like diabetic retinopathy and AMD. She also created a mouse model that is widely used for the investigation of proliferative retinopathies. An author of over 170 peer-reviewed papers and recipient of numerous awards, including the António Champalimaud Vision Award, Dr. D’Amore focuses on microvasculature and AMD pathogenesis, exploring inflammation's role and the impact of vascular growth factors. Her contributions were recognized by her membership in the American Academy of Arts & Sciences fellowship.

• Biological sciences

Wael M.Y. Mohamed, MD, PhD

Editor-in-Chief, Global Neuroscience and Brain Health · 2026–present

International Islamic University Malaysia

Dr. Wael M.Y. Mohamed is a neuroscientist, medical doctor, and translational researcher whose work bridges the molecular and clinical frontiers of neurodegenerative and neuropsychiatric disorders. He is currently a Professor at the International Islamic University Malaysia (IIUM), where he also leads multiple research programs focused on Parkinson’s and Alzheimer’s diseases, leveraging zebrafish and rodent models to explore genetic, inflammatory, and nutraceutical dimensions of brain health. Trained in Egypt and the United States—with a Ph.D. in Neuroscience from Penn State University—Dr. Mohamed’s early work on iron deficiency’s cognitive effects in rats laid the foundation for a prolific career that now spans more than 90 peer-reviewed articles, 10 books, and numerous international collaborations. As the founder of the AfrAbia Society and a key contributor to the Global Parkinson’s Genetics Program, Dr. Mohamed has championed genomic research in underrepresented populations, leading multi-country consortia supported by The Michael J. Fox Foundation. His editorial footprint includes roles at PLOS ONE, Scientific Reports, Frontiers in Neurology, and Annals of Neuroscience, among others. He also serves on international scientific committees including the Movement Disorders Society and the International Zebrafish Society, and he’s a frequent speaker at IBRO schools, Keystone Symposia, and FENS forums. His research and advocacy reflect a deep commitment to advancing neuroscience through inclusive, collaborative, and interdisciplinary science diplomacy. Alongside his publishing and research activities, Dr. Mohamed is deeply invested in capacity building and academic mentorship. He has supervised numerous master's and Ph.D. students across Egypt, Malaysia, and South Africa, and has served as an examiner for theses at institutions spanning Africa, Asia, and Europe. He has also played a pivotal role in strengthening neuroscience communities through the organization and leadership of over 20 international conferences, symposia, and IBRO schools. From coordinating Brain Bee competitions to founding the AfrAbia Chapter of the Society for Neuroscience, Dr. Mohamed continues to foster environments where emerging researchers can thrive.

• Basic medicine
• Clinical medicine

Martha E. Londoño, PhD

Editor-in-Chief, Biomedical Engineering · 2026–present

EIA University

Dr. Martha Elena Londoño, a distinguished researcher in Biomedical Engineering at EIA University with a Ph.D. in Engineering, has made significant contributions across 25 publications. Her research primarily focuses on healthcare innovations, particularly developing nanomaterials and advancing biomedical materials to tissue replacement. Key highlights of her work include developing and characterizing an injectable bone substitute combining PVA/Borax/CaCO3 with Demineralized Bone Matrix and creating nanomaterials like nanoparticles like nanorods from Colombian biodiversity and carbon dots from sources like spruce trees and African oil palm for ecotoxicity evaluation. Dr. Londoño's expertise also encompasses studying the bioactivity and degradation of bone substitute materials and the characterization of complex biomedical matrices. Her work in fluid dynamics within biological systems further showcases her diverse research interests in biomedical engineering. Her contributions are instrumental in advancing diagnostic and material technologies in healthcare, underlining her role as a leading figure in biomedical research and innovation.

• Medical engineering

Joshua Sandhu

Editor-in-Chief, ScienceBank Community: News & Opinions · 2026–present

ScienceBank

Josh drives growth at ScienceBank, helping to build a thriving scientific community with expanding strategic partnerships. Focusing on enhancing collaboration and networking between academics globally.

• Other natural sciences

John Mesa, MD

Editor-in-Chief, Plastic Surgery · 2026–present

University of Antioquia

Dr. John Mesa, a Harvard-educated, triple fellowship-trained, and board-certified Plastic Surgeon, excels in facial contouring with a global reputation for natural, youthful results. Practicing in New York City, New Jersey, and Miami, Dr. Mesa is renowned for pioneering painless, fully awake facelifts and neck lifts under local anesthesia. He is also well-known for his results in buccal fat removal and extended chin liposuction under local anesthesia, further showcasing his expertise in enhancing facial aesthetics. His surgical prowess in cosmetic plastic surgery, focusing on the face and neck, is complemented by personalized care. Dr. Mesa's comprehensive training includes residencies and fellowships at Harvard, Pennsylvania State University, the University of Michigan, and the University of Alabama. He holds multiple memberships in prestigious societies such as the American Society of Plastic Surgeons and the International Society of Aesthetic Plastic Surgery. Dr. Mesa's educational journey began at Universidad de Antioquia in Colombia. His commitment to education continues as a former clinical instructor and author of numerous academic papers and a craniofacial surgery book. He is a sought-after speaker, sharing his innovative techniques in facelift and neck lift surgeries globally, shaping the future of cosmetic surgery.

• Clinical medicine

Carlos Builes Barrera, MD

Editor-in-Chief, Endocrinology · 2026–present

University of Antioquia

Dr. Carlos Alfonso Builes Barrera is a doctor from the University of Antioquia, a specialist in Internal Medicine, and a sub-specialist in Endocrinology. His main focus of study and clinical practice is with patients with benign thyroid dysfunction. He has written multiple articles in local and some international journals in different fields of endocrinology. He likes and is passionate about being an educator and communicator of medical art in simple words for patients. He has written books for patients: What's Wrong with My Thyroid, Diabetes More Than High Sugar, and Pituitary: The Central High Command. For his colleagues, "A Treatise on Thyroid and Key Aspects of Thyroid and a Doctor at Heart" is a book that highlights the importance of empathy in the medical act. Dr Builes is passionate about the Thyroid, building the Rubik's cube, and being a lecturer locally and internationally.

• Clinical medicine

Manuel Navarro González, BVSc, PhD

Editor-in-Chief, Toxicology · 2026–present

Australian Department of Health

Manuel undertook his Veterinary Medicine studies at Caldas University (Colombia) and his PhD (Neuroscience) at the Australian National University (ANU). Manuel’s research at the ANU, Harvard Medical School, and The Canberra Hospital, resulted in publications on the regulation of cerebral blood vessel tone, as well as on the pathogenesis of neurological and proliferative diseases. Manuel is now a Toxicologist with the Department of Health (Australia), assessing the safety and efficacy of new medicines.

• Basic medicine

Paula Pérez Corredor

Editor-in-Chief, Basic Biomedical Advances · 2026–present

Harvard Medical University

With over a decade of professional experience, she currently serves as a Scientific Specialist at Mass Eye and Ear/Harvard Medical School, where she applies her expertise in research and molecular biology. Previously, she contributed as a Researcher in the Neuroscience Group of Antioquia at the University of Antioquia, further strengthening her expertise in neuroscience. Her mission is to advance scientific knowledge by integrating an interdisciplinary and collaborative approach that aligns with the values and goals of her organization. At MEEI/Harvard, she brings diverse perspectives and research experience to support the team’s projects and contribute to scientific progress.

• Basic medicine

Lucía González Buendía, MD

Editor-in-Chief, Clinical Ophthalmology · 2026–present

Puerta de Hierro University

Dr. Lucía González Buendía, an ophthalmologist at IMO Miranza and Puerta de Hierro University Hospital, Madrid (Spain), specializes in retina and vitreous, focusing on diseases like AMD, diabetic retinopathy, and inherited retinal disease. She completed her residency at the Clinical Hospital of Valladolid (Spain) and furthered her expertise in Medical Retina at IOBA Eye Institute (University of Valladolid, Spain). She also completed fellowships in research in neuroprotection and angiogenesis at Angiogenesis Laboratory and Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School (USA). Dr. González Buendía is recognized for her contributions to developing new therapies for retinal diseases such as retinal degeneration and aberrant ocular angiogenesis. She is involved in over 20 international clinical trials and has received multiple awards in her field. In addition to her clinical work, she acts as Research Coordinator at IMO Miranza and Study Coordinator at Puerta de Hierro-University Hospital. She also collaborates as a consultant at Schepens Eye Research Institute, Harvard Medical School. Her extensive research and publications showcase her commitment to advancing ocular health.

• Clinical medicine

Ilya Ioshikhes, PhD

Editor-in-Chief, Big Data and Personalized Medicine · 2026–present

Humber College

Dr. Ilya Ioshikhes is an expert in Bioinformatics with a PhD in Structural Biology/Chemistry from Weizmann Institute of Science and an MSc in Physics from Tajik State University. His academic career includes positions as Associate Professor at the Ottawa Institute of Systems Biology, Assistant Professor at Ohio State University (where he directed the Bioinformatics Core Facility at Davis Heart and Lung Research Institute), and most recently as a part-time Professor at Humber College, Toronto. His research focuses on bioinformatics approaches to studying gene regulation, genomics, and metagenomics, with particular emphasis on algorithm development in these areas. Throughout his career, he has published articles in prestigious international and regional journals, such as Nature, Nature Genetics, and BMC Genomics, where he has contributed significant findings in nucleosome organization, genome mapping, and gene regulation mechanisms. His multilingual capabilities in Russian, Hebrew, English, French, and Ukrainian have facilitated international collaboration throughout his career.

• Computer and information sciences

Gerda Fouche

Editor-in-Chief, Medicinal Plants · 2026–present

University of Pretoria

Dr. Gerda Fouche is an extraordinary lecturer in the Department of Chemistry within the Faculty of Natural and Agricultural Sciences at the University of Pretoria. She earned her doctorate from the University of South Africa in 1991, with a thesis titled “Exploratory Organic Chemistry and Synthetic Methodology.” Since 2018, she has been involved in supervising postgraduate research projects for students in both the Department of Chemistry and the Paraclinical Sciences Department of Veterinary Science. Dr. Fouche has served as the scientific innovation leader for the Natural Product Group at CSIR Biosciences. From 1998 to 2017, she conducted research at the CSIR, mentoring and supervising postgraduate students in the study of medicinal and indigenous plants of southern Africa. Her research projects aimed at discovering and developing drugs and natural product leads from South Africa's biodiversity, focusing on the purification, isolation, and structural elucidation of active compounds from these medicinal plants. She holds six granted international patents in natural product chemistry and has published more than 70 peer-reviewed articles in international journals. Additionally, she co-authored the book “South African Pharmacopoeia of Medicinal Plants,” published in 2022, which compiles information on the twenty-five most significant medicinal plants in South Africa. Over the past five years, she has served as managing editor for both the Journal of Ethnopharmacology and the Journal of Herbal Medicine.

• Basic medicine

Claudia Marino, PhD

Editor-in-Chief, Neurodegenerative Disorders of Aging · 2026–present

University of Texas Medical Branch

Dr. Claudia Marino is a distinguished neuroscientist with a profound focus on Alzheimer's disease and related neurogenerative disorders. With dual Ph.D. degrees from the University of Palermo, Italy, and The University of Texas Medical Branch at Galveston, Texas, Dr. Marino's research has significantly contributed to understanding the molecular mechanisms underlying Alzheimer's disease and to characterizing protective synthetic and biological inhibitors of amyloid beta neurotoxicity, one hallmark of Alzheimer’s Disease. During the past five years, Dr. Marino's primary research interest lies in characterizing novel pathways of resilience against Alzheimer's disease to develop innovative disease-modifying therapies. During their postdoctoral tenure in Dr. Arboleda-Velasquez’s laboratory, Dr. Marino explored biophysical, biomolecular, and physiological mechanisms to prevent or delay Alzheimer's onset. Notably, they investigated rare genetic mutations in the RELN gene (RELN-COLBOS) and developed antibodies targeting Apolipoprotein E, a significant risk factor for sporadic Alzheimer's disease. Her scholarly work includes several peer-reviewed publications and presentations at national and international conferences, highlighting their contributions to understanding Alzheimer's disease mechanisms and potential therapeutic interventions.

• Clinical medicine

Jan Manent, PhD

Editor-in-Chief, Development and Stem Cells · 2026–present

Australian Regenerative Medicine Institute

Dr. Jan Manent is a researcher and academic coordinator at the Australian Regenerative Medicine Institute in Melbourne, where he studies early patterning of the vertebrate embryo. Educated at Pierre and Marie Curie – Sorbonne University in Paris, France, Jan has a rich history in the academic and biotechnology environments, with postdoctoral trainings at the Harvard Medical School and Peter MacCallum Cancer Center, and as a research scientist at Cell Mogrify. He is also an executive board member of the Australia and New Zealand Society for Cell and Developmental Biology. With over 20 peer-reviewed research articles, Jan’s expertise lies in Developmental Biology, Stem Cells, Genomics and Genetics. His career showcases a dedication to advancing research and mentoring in the scientific community.

• Biological sciences

Nayara Mota, PhD

Editor-in-Chief, Neuropsychology · 2026–present

Catholic University of Salvador

Nayara Mota is a Clinical Neuropsychologist and Professor of Psychology at the Catholic University of Salvador (UCSAL), bringing extensive international experience in neuropsychological research and clinical practice. Her academic journey includes two prestigious postdoctoral positions at the University of California, San Francisco (UCSF), one at the Center for Imaging of Neurodegenerative Disorder in collaboration with the San Francisco Veterans Affairs Medical Center (SFVAMC), and another at the Biomagnetic Imaging Laboratory. Dr. Mota holds a PhD with highest honors (cum laude) and a master's degree in Psychobiology from the Santiago de Compostela University (USC), where she received an extraordinary doctorate award. She further specialized with a professional master's degree in Neuroscience from Barcelona University and completed her undergraduate studies in Psychology at the Federal University of Bahia (UFBA) in Brazil. Currently, she also serves as an Adjunct Professor of Neuropsychology at the Rio de Janeiro State University (UERJ) and contributes to the academic community as a Guest Associate Editor for Frontiers in Human Neuroscience. Her clinical expertise spans three countries–Spain, the United States, and Brazil–where she has provided neuropsychological care in various settings, including neurological units, outpatient clinics, and rehabilitation centers. Dr. Mota has also made significant contributions to educational neuroscience through her work in school management and neuropsychological assessment, focusing on both typical and atypical development in children aged 1 to 15 years. In her private practice, she conducts comprehensive neuropsychological assessments and rehabilitation across diverse age groups and clinical conditions. As an active member of leading international neuropsychology and neuroscience societies and a qualified Judicial Expert, Dr. Mota's research focuses on understanding individual differences in neurodevelopment. She is particularly interested in characterizing and enhancing socioemotional regulation through neuropsychological stimulation and generative artificial intelligence. Her ultimate goal is to advance cooperative wellbeing, with a special emphasis on supporting individuals with neurological vulnerabilities by fostering prosocial behaviors, emotional bonds, and social connections.

• Psychology

Leo Kim, PhD

Editor-in-Chief, Translational Ophthalmology and Visual Science · 2026–present

Harvard Medical School

Dr. Leo Kim, an esteemed retina surgeon at Mass Eye and Ear, is an expert in managing retinal diseases related to neovascularization and fibrosis, such as diabetic retinopathy, age-related macular degeneration, and proliferative vitreoretinopathy. Educated at Yale University School of Medicine, Dr. Kim completed his MD/PhD, followed by an ophthalmology residency at the University of Southern California/Doheny Eye Institute, where he earned several accolades for his research. He was also recognized by the Heed Ophthalmic Foundation for his potential in academic ophthalmology. In his current role, Dr. Kim's research, supported by the National Eye Institute and Department of Defense, delves into vitreoretinal disease mechanisms, particularly looking at the molecular mechanisms of pathologic ocular angiogenesis and fibrosis. These two pathological processes drive several retinal diseases, including exudative age-related macular degeneration, proliferative diabetic retinopathy, and proliferative vitreoretinopathy. Dr. Kim is deeply involved in the academic community, providing clinical supervision and training to medical residents and fellows. He also runs a basic science laboratory training the next cohort of vision science researchers. He has presented his work investigating the pathophysiology of retinal disease in multiple national and international forums.

• Clinical medicine

DanVictor Ebirim, MD

Editor-in-Chief, Cardiology · 2026–present

Federal University Teaching Hospital

Dr. DanVictor Ebirim is a Consultant Cardiologist at the Federal University Teaching Hospital in Owerri, Nigeria, a position he has held since September 2018. Prior to this, he was a Senior Registrar in Cardiology at the Federal Medical Centre Owerri from June 2016 to August 2018 and at the University of Port Harcourt Teaching Hospital from December 2014 to April 2016. Dr. Ebirim's career in cardiology began with his training at the Federal Medical Centre Owerri, where he worked from September 2010 to April 2013. He also served as a Junior Resident in internal medicine and a Medical Officer at Health Centre Mbano before joining the Federal Medical Centre Owerri as a Medical Doctor. He completed his cardiology fellowship (FWACP) at the West African College of Physicians between January 2011 and August 2018, after obtaining his medical degree from the University of Calabar (2001-2008). Dr. Ebirim's career demonstrates a sustained commitment to advancing cardiology in various healthcare settings.

• Clinical medicine

Taruna Ikrar, PhD

Editor-in-Chief, Pharmacology · 2026–present

Universitas Malahayati Bandar Lampung

Dr. Taruna Ikrar, a distinguished Indonesian physician and scientist, serves as the Chairman of the Indonesian Medical Council. He is also currently the President of the Gene & Cellular Immunotherapy Institute, Royal Prima Hospital in Medan. Born in Makassar, he pursued medicine at the Hasanuddin University and a Master's in Pharmacology at the University of Indonesia. He then specialized in heart diseases at the Niigata University in Japan for his Ph.D., supported by a Japanese government scholarship. His post-doctoral research in neuroscience was conducted at the University of California, Irvine, supported by the National Institute of Health in the USA. Renowned in pharmacology, cardiology, and neuroscience, Dr. Ikrar is the Director of the International Association of Medical Regulatory Authorities and is associated with several national and international medical bodies. He has written numerous articles and books for various top-tier publications and is set to teach as a professor at Malahayati University's Department of Pharmacology, Biomedical, and Neuroscience. Additionally, he is an adjunct professor at the Faculty of Military Medicine, the Republic of Indonesia Defense University (the prestigious government university in Indonesia). Significant medical and academic achievements mark Dr. Ikrar's career.

• Basic medicine

Jesse Berry, MD

Editor-in-Chief, Liquid Biopsy · Ocular Oncology · 2026–present

Ocular Oncology at USC University

Dr. Jesse L. Berry, MD, a Harvard-educated, board-certified ophthalmologist specializing in ocular oncology, is the Director of the Ocular Oncology and Retinoblastoma Program at Children's Hospital Los Angeles and a Professor at Keck School of Medicine of USC. She completed her ophthalmology residency at the University of Southern California and a fellowship in Ocular Oncology at Children's Hospital Los Angeles. Renowned for treating eye cancers like retinoblastoma and uveal melanoma, Dr. Berry's research is groundbreaking in using aqueous humor as a liquid biopsy for retinoblastoma. Her research is funded by the National Cancer Institute (R01CA282759). Dr. Berry holds significant roles in professional societies, including the International Society of Ocular Oncology, and is a committed mentor and advocate within the ophthalmology community. She founded Women in Ocular Oncology (WOO) and participates in mentorship programs. Her academic excellence is recognized with her promotion to Associate Professor and appointment to the USC Berle and Lucy Adams Chair in Cancer Research and A. Linn Murphree, MD Chair in retinoblastoma at Children's Hospital Los Angeles.

• Clinical medicine

Javier Camacho

Associate Editor, Biomedical Engineering · 2026–present

EIA University

Biomedical engineer with experience in technology management, and innovation processes focused on health data analytics. Possesses in-depth knowledge of implementing projects based on big data and artificial intelligence in health and clinical engineering. Extensive experience in the analysis, evaluation, and management of projects focused on the assessment and provision of medical devices, telemedicine, and improvement and control activities in institutional accreditation processes through the development of quality-based strategic approaches. Served as an editor for the journal Health and Technology for three years. Consultant in technology management, risk-based maintenance, and structured technovigilance using FMEA. Regular contributor to the WHO, IFMBE, and CEGlobal. Author of various scientific articles and a regular contributor to the Latin American journal El Hospital.

• Medical engineering

Daniel Morales

Associate Editor, Nuclear Science and Technology · 2026–present

Universidad de Antioquia

Dr. Daniel Morales is a nuclear physicist specializing in low-energy theoretical nuclear physics. He contributes to advancing nuclear science education and capacity building in Colombia through academic, teaching, and outreach activities. Dr. Morales earned his undergraduate degree in Physics from the University of Antioquia and completed both his Master’s and Ph.D. in Nuclear Physics at the University of São Paulo (USP), Brazil. His doctoral research, conducted under the supervision of Professor Luiz Carlos Chamón, focused on theoretical models of nuclear structure and low-energy nuclear reactions. He currently serves as an educator within the Medellín Secretary of Education and as an adjunct professor at the University of Antioquia, where he is actively involved in teaching physics and nuclear science. In addition, he coordinates the Nuclear Energy Diploma Program at the university, contributing to the development of specialized training programs aimed at strengthening national expertise in nuclear technologies. Dr. Morales is also a co-founder of the Colombian Nuclear Network, where he supports initiatives to promote the peaceful use of nuclear science and technology, foster public understanding, and build professional communities across academia, industry, and government. Through his work in education, research dissemination, and institutional development, Dr. Morales plays an important role in cultivating the next generation of nuclear scientists and professionals in Colombia and Latin America.

• Physical sciences

Hermes Llanes

Associate Editor, Nuclear Science and Technology · 2026–present

Universidad de la Salle

Hermes Llanes is an electrical engineer with extensive experience in power systems, renewable energy, and energy infrastructure across the oil, gas, mining, and industrial sectors. His professional career includes significant contributions to major organizations such as Schlumberger BP Exploration Colombia, Drummond Ltd., Acerías Paz del Río, and Ecopetrol, where he has worked on complex energy and operational projects. In 2023, he was awarded the Certified Nuclear Security Specialized Professional (CNSsP) credential by the World Institute for Nuclear Security (WINS), recognizing his expertise in the physical protection and security management of radioactive sources. In 2024, he completed the Nuclear Energy Diploma Program at the University of Antioquia, further strengthening his engagement with nuclear science and technology. Mr. Llanes holds a degree in Electrical Engineering from Universidad de La Salle and a specialization in Electric Power Transmission and Distribution Systems from Universidad de los Andes. He also holds two master’s degrees: a Master of Business Administration (MBA) from Universidad Externado de Colombia and a Master’s in Logistics and Operations Management from ENAE Business School, University of Murcia, Spain. He is currently completing a Master’s degree in Renewable Energy at Universidad del Rosario. In addition to his professional and academic work, Mr. Llanes has authored several science outreach publications, contributing to the dissemination of knowledge on energy systems, sustainability, and emerging technologies. Through his multidisciplinary background in engineering, management, logistics, and nuclear security, Mr. Llanes brings a systems-oriented perspective to the development of reliable, secure, and sustainable energy solutions.

• Physical sciences

Camilo Prieto Valderrama

Associate Editor, Nuclear Science and Technology · 2026–present

Universidad Javeriana

Dr. Camilo Prieto is an Academic Ambassador in Colombia for the World Institute for Nuclear Security (WINS) and a professor in the Master’s Program in Energy and Sustainability at Pontificia Universidad Javeriana. He contributes to advancing interdisciplinary dialogue on nuclear security, sustainable energy systems, and the societal dimensions of emerging technologies. Dr. Prieto is also a researcher, where his work focuses on the peaceful applications of nuclear science, energy transitions, and the interface between technology, policy, and society. His multidisciplinary background bridges medicine, engineering, and the humanities, enabling a comprehensive perspective on complex technological challenges. He is a medical doctor and reconstructive surgeon, currently pursuing a Ph.D. in Engineering with an emphasis on energy. He holds master’s degrees in Energy and Sustainability and in Philosophy, reflecting a strong commitment to both technical rigor and ethical reflection in the development and use of advanced technologies. In addition to his academic and clinical work, Dr. Prieto is an active science communicator and public intellectual. He has authored several books aimed at disseminating scientific knowledge to broader audiences, promoting evidence-based discussion on energy, environment, and technological development. Through his academic, research, and outreach activities, Dr. Prieto contributes to strengthening public understanding of nuclear science and its role in sustainable development, health, and environmental protection.

• Physical sciences

Alexander Navarro

Associate Editor, Nuclear Science and Technology · 2026–present

Universidad de Antioquia

Alexander Navarro Roldán is project management graduate candidate with multidisciplinary experience at the intersection of clinical research, health systems, and scientific applications of advanced technologies, including those related to radiological and nuclear domains in medicine. Over more than a decade at the Neurosciences Group of Antioquia (GNA), he has coordinated complex Phase I–III clinical trials, ensuring strict regulatory compliance, traceability, and operational control in studies involving advanced diagnostic and therapeutic procedures. Mr. Navarro holds a degree in Business Administration from Fundación Universitaria María Cano, complemented by technical training in pharmacy and nursing support, and is currently pursuing a Master’s degree in Project Management at Universidad Pontificia Bolivariana. This combination of administrative, clinical, and technical competencies enables him to support research environments where precision, safety, and regulatory rigor are essential—particularly in contexts involving medical technologies that may include radiological components. His professional work includes oversight of pharmaceutical management, clinical protocol implementation, quality assurance processes, and regulatory coordination under standards aligned with Good Clinical Practice and national health authorities. He has contributed to the secure handling of investigational products, data integrity systems, and institutional procedures that underpin safe clinical research operations, including studies relevant to neurological diseases where advanced imaging and radiological techniques are frequently employed. In academia, Mr. Navarro serves as a lecturer in toxicology at the University of Antioquia, delivering both theoretical and practical training on emergency response, exposure management, and risk mitigation for hazardous substances—competencies closely related to radiological preparedness and public health protection frameworks. He has also participated in international research collaborations on neurodegenerative diseases, including Alzheimer’s disease, working with institutions such as Harvard University and Massachusetts General Hospital. His contributions include coauthorship of peer-reviewed publications addressing clinical neuroscience, genetics, and population health, fields that increasingly rely on advanced imaging and molecular techniques. Beyond his clinical and academic roles, Mr. Navarro contributes to science outreach as a volunteer with the Colombian Nuclear Network, supporting initiatives that promote the peaceful applications of nuclear science and radiation technologies in medicine, energy, industry, and environmental protection. Through his integrated experience in research management, health sciences, and technological systems, Mr. Navarro brings a safety-oriented, multidisciplinary perspective to scientific initiatives involving complex technologies, risk management, and evidence-based innovation in nuclear and radiological applications.

• Physical sciences

Yaneth Miranda-Brand

Associate Editor, Basic Biomedical Advances · 2026–present

Universidad de Antioquia

Yaneth Miranda-Brand is a microbiologist and bioanalyst, and holds a PhD in Basic Biomedical Sciences from the University of Antioquia (Colombia). She is currently a researcher in the Neurosciences Research Group at the University of Antioquia. Her research career spans more than 15 years, with a focus on the bioactivity of natural derivatives and synthetic compounds with antiviral, cytotoxic, and neuroprotective potential. Her expertise encompasses cellular and molecular biology, as well as the mechanisms underlying viral infection pathogenesis. Her work also extends to translational research, where she has contributed to studies on extracellular vesicles derived from patients with CADASIL, aiming to advance the understanding of disease pathophysiology and to identify potential protective and therapeutic mechanisms.

• Basic medicine

Priyanka Bhoj, PhD

Associate Editor, Pharmacology · 2026–present

Temple University

Dr. Priyanka Bhoj is a biochemist and publishing professional with a strong track record in both scientific research and editorial leadership. She earned her Ph.D. in Biochemistry from RTM Nagpur University (India), where she studied the microbiological and molecular biology of parasitic nematodes, including drug screening and vaccine development. She later pursued research fellowships and editorial positions across India and the United States, and recently completed an Assistant Scientist role at Temple University, where her work focused on biological chemistry and neurovascular mechanisms, particularly in the context of alcohol-induced blood–brain barrier damage. Her scientific expertise spans molecular biology, immunology, pharmacology, microbiology, autoimmune diseases, and infectious diseases. She has published over 25 peer-reviewed articles and contributed to several research topics as Guest Editor and Editorial Advisor, including Frontiers in Cellular and Infection Microbiology, where she led high-impact collections on antimicrobial resistance and infectious disease research. Her editorial experience also includes roles at Springer Nature, JoVE, AJE, and Cactus Communications, where she led peer review processes, special issues, and author engagement initiatives. Dr. Bhoj has also contributed as a peer reviewer for more than 10 journals across microbiology, immunology, neurobiology, and molecular science. She is co-inventor of a patented quinoxaline compound targeting filarial parasites, and is currently completing a diploma in Clinical Trial Management at Temple University. Her recent research explored type I interferon–driven immune responses in systemic and neuropsychiatric lupus.

• Basic medicine

Ngozi Lina Ekeigwe, FWACP

Associate Editor, Cardiology · 2026–present

Federal University Teaching Hospital

Dr. Ngozi Lina Ekeigwe is a consultant rheumatologist at the Federal University Teaching Hospital in Owerri, Nigeria. She has over a decade of experience in internal medicine, having previously served as a resident at the same hospital and as a medical officer at the Nigerian Ministry of Defense. Her academic and clinical focus lies in the diagnosis and management of autoimmune and rheumatic diseases, with a special interest in lupus and systemic vasculitis. Her research includes studies on systemic lupus erythematosus and eosinophilic granulomatosis with polyangiitis. She has made significant contributions to understanding the pattern of autoimmune diseases in Nigeria, with her research focusing on local presentations and treatment outcomes. Dr. Ekeigwe is a member of several professional bodies, including the Nigerian Society of Rheumatology and the African League of Associations for Rheumatology.

• Clinical medicine

Sebastián Sánchez Góez, PhD

Associate Editor, Biomedical Engineering · 2026–present

International Uni of Valencia

Sebastián Sánchez, Data Scientist, holds a master’s degree in medical physics and a PhD in Technologies for Well-being and Health. His expertise focuses on software development for image reconstruction algorithms in C++, as well as applying Machine Learning and Deep Learning algorithms for developing predictive models and diagnostic aids. He has made significant contributions to academic research in physics and medicine through his work on PET designs, detector block performance, and the efficacy of treatments like vismodegib for basal cell carcinoma. Currently, he is a part-time professor in artificial intelligence, physics, and big data at the International University of Valencia. He has published in multiple journals, symposiums, and conferences.

• Medical engineering

Elisa Mejía Mejía, PhD

Associate Editor, Biomedical Engineering · 2026–present

RUSH University Medical Center

Elisa Mejía-Mejía holds a PhD in Biomedical Engineering from the City University of London. She is a Research Bioengineer at the Alzheimer's Disease Center at RUSH University Medical Center. Dr. Mejía-Mejía’s research primarily focuses on using cardiovascular and respiratory signals to assess autonomic function and understand the effects of aging and dementia on heart and lung function. Her main research interests lie in the development of medical devices and signal processing algorithms for the diagnosis, monitoring, and treatment of cardiovascular and mental diseases. Her work is at the forefront of creating innovative solutions to complex health challenges, making significant strides in medical technology and patient care.

• Medical engineering

Louie Alldawi, PhD

Associate Editor, Pharmacology · 2026–present

PhD Niigata University

Dr. Louie Alldawi, MD, Ph.D., is a Consultant Haematologist and Haematooncologist with certifications from the General Medical Council, UK, and the European Society of Hematology. He holds a Ph.D. in Haematology from Niigata University, Japan, and a Doctor of Medicine degree from Damascus University, Syria. With 20 years of international experience, including a decade as a consultant in the UK's National Health Service, Dr. Alldawi has expertise in general haematology and malignant blood disorders, offering specialised services for conditions like anaemia, leukaemias, and Rhesus disease. He has published over 20 peer-reviewed articles in prestigious journals.

• Basic medicine

Javier Martinez

Associate Editor, Nuclear Science and Technology · 2026–present

Universidad Nacional de Colombia

Javier Martínez is a Nuclear Instrumentation Engineer and Development Specialist at Argentina’s National Atomic Energy Commission (CNEA), where he works within the Instrumentation and Control Laboratory designing, qualifying, and maintaining electronic systems for nuclear facilities and medical applications. Trained as a Physical Engineer at the National University of Colombia (Medellín) and specialized in Technological Applications of Nuclear Energy at Instituto Balseiro, he combines strong theoretical foundations with hands-on expertise in safety-critical hardware for both research and power reactors. His work focuses on nuclear instrumentation, equipment qualification, and protection systems, including the design of amplifiers, radiation measurement devices, and seismic qualification methodologies for components used in nuclear power plants such as Atucha I and II, as well as research reactors like RA-10. He has led or contributed to the development of multiple qualified electronic units installed in operational facilities, adhering to stringent international standards for nuclear safety and reliability.  Beyond his engineering role, Martínez Espitia is an active educator and scientific communicator. He serves as a lecturer in nuclear engineering programs in Argentina and has taught instrumentation and control courses, helping train the next generation of nuclear professionals. He is also a founding member of the Colombian Nuclear Network (RNC), where he promotes public understanding of peaceful nuclear applications through outreach and educational initiatives.  His career uniquely bridges regulatory experience, research, industrial implementation, and academic teaching across Latin America, positioning him as a practitioner deeply engaged in the safe deployment of nuclear technology. He has participated in international training programs organized by the International Atomic Energy Agency (IAEA) and contributed to activities related to reactor technology, equipment qualification, and radiological protection.

• Physical sciences

Luis Fernando Guarín Cabrera

Associate Editor, Nuclear Science and Technology · 2026–present

Universidad Nacional de Colombia

Luis Fernando Guarín Cabrera, MSc, PhD(c) is a chemical engineer and nuclear technology specialist with expertise in experimental reactor systems, neutron activation analysis, and radiation protection. He contributes to advancing nuclear research, education, and technological applications through both academic teaching and applied investigation. Mr. Guarín Cabrera holds a Master’s degree in Molecular Simulation, a specialization in Technological Applications of Nuclear Energy, and a degree in Chemical Engineering. He is currently a PhD candidate, further developing his research in nuclear science and engineering. He served as a faculty member and researcher at Instituto Balseiro (Argentina), where he taught courses in Nuclear Measurements, Experimental Physics, and Elements of Research Reactors. His academic and research activities focus on experimental nuclear techniques and reactor-based applications. His research interests include neutron activation analysis, prompt gamma neutron activation analysis (PGNAA), radiochemistry, radiation protection, and the operation and characterization of research reactors. He has contributed to the development and safety assessment of PGNAA instrumentation at the RA-6 research reactor and has conducted studies on radioisotope activity in reactor cooling systems. His work also includes computational studies of neutron interaction properties in supercritical water using molecular dynamics. Through his interdisciplinary expertise spanning nuclear engineering, chemistry, and computational modeling, Mr. Guarín Cabrera supports the advancement of nuclear science for research, industrial applications, environmental monitoring, and technological innovation.

• Physical sciences

Tábata Barbosa

Associate Editor, ScienceBank Archive · 2026–present

Tábata Barbosa is a biologist and Head of Publishing at ScienceBank. Her research sits at the intersection of computational biology and molecular medicine. Her background bridges scientific research in computational biology with leadership in professional scientific publishing platforms.

• Other natural sciences

Sun Young Lee, PhD

Associate Editor, Translational Ophthalmology and Visual Science · 2026–present

Keck School of Medicine

Dr. Sun Young Lee was born and raised in South Korea. She trained at Asan Medical Center in Seoul, where she completed her ophthalmology residency and vitreoretinal surgery fellowship. After moving to the USA, she became a board-certified retina surgeon and clinician-scientist, undergoing additional training at top ophthalmology programs, including Johns Hopkins University, the University of Southern California, and the University of Iowa. Dr. Lee has extensive experience managing complex vitreoretinal diseases such as age-related macular degeneration, inherited retinal diseases, and diabetic retinopathy. Her current research focuses on the role of extracellular vesicles (EV), particularly exosomes, in retinal diseases and developing innovative EV-based intraocular therapies. Notable contributions to her field include studies on retinal cell biology, multi-omics of extracellular vesicles, and advanced imaging techniques for retinal diseases. Dr. Lee's research is currently supported by the National Eye Institute, Alcon Research Institute and The California Institute for Regenerative Medicine. She runs the LeeRetinaLab.

• Clinical medicine

Javad Sharifi Rad

Associate Editor, Medicinal Plants · 2026–present

Universidad Espíritu Santo

Dr. Javad Sharifi Rad is a Professor of Biomedical Sciences at Universidad Espíritu Santo in Ecuador, specialising in molecular oncology and pharmacognosy. Recognised as a Highly Cited Researcher by Clarivate’s Web of Science, he has made significant contributions to cancer biology and the therapeutic applications of natural products. His research integrates pharmacology and molecular biology to identify and characterise bioactive compounds from plants for cancer prevention and treatment. Investigations into compounds such as anethole, moscatilin, and homoharringtonine have elucidated their molecular mechanisms and translational potential in various cancer types. His work supports the development of phytochemicals as drug candidates, particularly for chemoresistant malignancies. Dr. Sharifi Rad also holds academic appointments at the Centro de Estudios Tecnológicos y Universitarios in Mexico and the University of Azuay in Ecuador. He has led and collaborated on multidisciplinary research initiatives spanning academia, healthcare, and industry. His global public health contributions include co-authorship in major international studies such as the Global Burden of Disease (GBD) initiative. He actively contributes to the scientific community as a reviewer for more than 30 international journals and participates in editorial activities supporting the advancement of biomedical research. Currently, Dr. Sharifi Rad leads research initiatives focused on developing innovative, plant-based therapeutic strategies and translational solutions to improve outcomes in treatment-resistant and complex cancers.

• Basic medicine

María Roldán, PhD

Associate Editor, Biomedical Engineering · 2026–present

University of London

María Roldán is a PhD in Biomedical Engineering from the University of London and MSc in Epidemiology from the CES University in Medellín, Colombia. She is CTO and Co-founder of Crainio, a company that develops technology to revolutionise intracranial pressure (ICP) measurement by creating non-invasive, cost-effective instruments. She was awarded the Worshipful Company of Engineers Mercia Award in 2022 for her research on non-invasive multimodal monitoring in traumatic brain injury. Dr. Roldán is devoted to creating biomedical solutions for healthcare challenges related to the brain through the methodical use of bioinstrumentation and clinical data. She has a wide experience in the full cycle of medical device R&D, including in-vitro studies, protocol development, ethical approval, clinical trials, data collection, analysis, publishing in academic journals, and patenting. She has strong skills in electronics, development of in-vitro testing set-ups, and systematic mental structure for new research protocols within ethical and regulatory considerations.

• Medical engineering

Sunny S. K. Chan, PhD

Associate Editor, Development and Stem Cells · 2026–present

University of Hartford

Dr. Sunny S. K. Chan is an Adjunct Professor in the Department of Biology at the University of Hartford and a stem cell biologist with over 15 years of research experience in stem cell biology, regenerative medicine, and tissue engineering. With a PhD in Pharmacology from the Chinese University of Hong Kong and dual undergraduate degrees in pharmacology and computer engineering from the University of British Columbia, Dr. Chan brings a multidisciplinary approach to biomedical research. His research has focused extensively on modeling early human development and disease through the use of pluripotent stem cells. Dr. Chan has developed advanced differentiation platforms to guide pluripotent stem cells toward cardiac and skeletal muscle lineages, enabling both mechanistic studies of development and translational applications. A major highlight of his work is the creation of a teratoma-based platform that generates engraftable muscle stem cells capable of regenerating damaged skeletal muscle in vivo—an innovation with therapeutic potential for Duchenne muscular dystrophy and other neuromuscular diseases. Additionally, Dr. Chan has pioneered the development of humanized disease models using patient-specific induced pluripotent stem cells (iPSCs), CRISPR-based genome editing, and single-cell transcriptomics to dissect the molecular pathogenesis of conditions such as congenital heart defects. His work bridges developmental biology and pharmacology by using these models to identify and validate new therapeutic targets and candidate drugs, particularly focusing on small molecules that modulate disease phenotypes. Dr. Chan’s research has been supported by grants from Regenerative Medicine Minnesota and the Greg Marzolf Jr Foundation and published in leading journals such as Nature Communications, Developmental Cell, and Cell Stem Cell. He is an active contributor to the peer-review process and scientific publishing, serving as a guest editor in Cells and a reviewer for journals including Stem Cell Reports and Cell Reports.

• Biological sciences

Marcello Iriti, PhD

Associate Editor, Medicinal Plants · 2026–present

University of Milan

Dr. Marcello Iriti is Associate Professor at the University of Milan. His multidisciplinary research focuses on bioactive phytochemicals—such as polyphenols, carotenoids, melatonin, and essential oils—and their roles in plant defense, human health, and disease prevention. He has investigated their antioxidant, anti-inflammatory, anticancer, neuroprotective and cardioprotective properties through preclinical models and human studies, with a particular emphasis on the health benefits of the Mediterranean diet and the ethnopharmacology of traditional remedies. A prolific author with over 300 publications, Dr. Iriti has been recognized among the world’s top 2% scientists by Elsevier and Stanford University. He holds patents related to chemoresistant cancer therapies and plant disease prevention. Dr. Iriti is an active reviewer and editor in several international journals. He is the Editor-in-Chief of the European Journal of Medicinal Plants, Academic Editor for PeerJ, Plos ONE and Frontiers in Nutrition. He also serves on the editorial boards of several other high-impact journals, including Food Chemistry: Molecular Science, Mini-Reviews in Medicinal Chemistry and Medicine. He is a founding member of the Italian Society of Environmental Medicine and contributes to advisory panels across Europe, including for the EU, Academy of Finland, and national research councils in France, Switzerland, Germany, and Hungary. Dr. Iriti is also a member of the World Academy of Sciences and the Asian Council of Science Editors.

• Basic medicine

Patrícia Pereira, PhD

Associate Editor, Toxicology · 2026–present

University of Aveiro

Dr. Patrícia Pereira is a Researcher at the Department of Biology and the Centre for Environmental and Marine Studies (CESAM) at the University of Aveiro, Portugal. With a PhD in Biology from the same institution, her research is specialized in aquatic toxicology, with a focus on neurotoxicity, neuroprotection, and behavior. Dr. Pereira has pioneering work on the neurotoxic effects of mercury in fish—especially inorganic mercury, previously considered of low risk to aquatic organisms—revealing its profound impact on brain morphometry, neurophysiology, and behavior. Her recent research has extended into evaluating the neurotoxicity of pesticides using Caenorhabditis elegans as a model organism, and exploring the neuroprotective potential of marine macroalgae. She currently leads the “Neurotoxicity, Neuroprotection and Behavior” research line and has established a dedicated C. elegans facility at her department, integrating innovative toxicological assays with behavioral and biochemical endpoints. Dr. Pereira's mechanistic and comparative neurotoxicity research supports biomedical understanding of how contaminants affect nervous systems. Using non-human model systems—primarily fish and nematodes—her research provides insights into sensory impairment, brain cell deficits, and behavioral changes caused by environmental contaminants. These findings align closely with biomedical toxicology themes and expand the relevance of her work beyond environmental health to include human neurological risk assessment. Dr. Pereira actively contributes to the scientific community through frequent peer reviewing, editorial roles in Fishes, Toxicology Reports, and Frontiers in Toxicology, and public engagement in science communication. Read more about her research on CIÊNCIAVITAE.

• Basic medicine

Daniele Corbo

Associate Editor, Neurodegenerative Disorders of Aging · 2026–present

University of Brescia

Dr. Daniele Corbo is a research fellow at the Department of Medical and Surgical Specialties, Radiological Sciences and Public Health at the University of Brescia, specializing in neuroimaging applications to psychiatric and neurological disorders. With a PhD in Neuroscience from the Second University of Naples and a background in biomedical physics, he has built an interdisciplinary career spanning neurocognitive dysfunction, neurodegeneration, and psychiatric imaging. Dr. Corbo's research leverages structural and functional MRI to explore conditions such as schizophrenia, borderline personality disorder, Parkinson’s disease, and post-COVID brain changes. He has played key roles in large-scale collaborative projects like CLIMAMITHE and I-ADNI and has authored nearly 50 peer-reviewed publications in journals including NeuroImage: Clinical, JAMA Neurology, Translational Psychiatry, and Alzheimer’s & Dementia. Beyond his research, Dr. Corbo has widely contributed to the academic community through peer review, as well as serving as section editor for Brain Sciences and as editor across Frontiers journals. He is also active in academic teaching, lecturing on cerebrospinal imaging, MR scanner technology, and medical physics in several Italian degree and postgraduate programs.

• Clinical medicine

Jiabin Shein, PhD

Associate Editor, Neuropsychology · 2026–present

University of Massachusetts Lowell

Dr. Jiabin Shen is an Assistant Professor of Psychology and Co-Director of Center for Autism Research and Education (CARE) at the University of Massachusetts Lowell. Dr. Shen is an expert in pediatric injury prevention, cognitive rehabilitation, and applied developmental psychology. His research focuses on the intersection of technology and child health, with a particular interest in children with neurodevelopmental conditions such as ADHD, autism spectrum disorder, and traumatic brain injury (TBI). Dr. Shen earned his Ph.D. in Life-Span Developmental Psychology from the University of Alabama at Birmingham and has since developed a strong program of research applying virtual reality and data science to public health challenges. His work has been featured in leading journals including Journal of Pediatric Psychology, Health Psychology, The Lancet Public Health, JAMA Network Open, Clinical Psychology Review, and Child Development. Dr. Shen has received national recognition and competitive funding for projects that span cognitive rehabilitation for children with TBI, health service disparities among children with autism, and the development of virtual and augmented reality tools to reduce implicit bias in healthcare. His research also addresses long-term outcome disparities in brain injury recovery, patient-centered intervention design, and injury prevention through community-based and family-oriented strategies. He has led or co-led interdisciplinary collaborations across psychology, rehabilitation, public health, and computer science to translate complex data into meaningful clinical applications. A committed mentor and scientific leader, Dr. Shen serves on the editorial boards of Journal of Pediatric Psychology and Frontiers in Public Health, and is a Consulting Editor for Rehabilitation Psychology. He is an active reviewer for several high-quality academic journals and grants. He holds leadership positions within the American Psychological Association and the American Congress of Rehabilitation Medicine, and continues to champion innovation and equity in pediatric health research and training.

• Psychology

Ignazio Restivo, PhD

Associate Editor, Medicinal Plants · 2026–present

University of Palermo

Dr. Ignazio Restivo is a biochemist whose research explores the cellular and molecular effects of dietary phytochemicals on inflammation, redox balance, and programmed cell death, with a focus on disease models such as metabolic syndrome, neurodegeneration, and colorectal cancer. Currently a postdoctoral researcher at the University of Palermo, he leads investigations on the bioactive compounds of Opuntia ficus indica and their potential in preventing intestinal neoplastic transformation. He has also contributed to comparative studies on the cytotoxicity of tobacco-derived products and to research on insulin-related neurodegeneration. Dr. Restivo earned his PhD in Molecular and Biomolecular Sciences at the University of Palermo, including a research stay at the University of Valencia. His doctoral work revealed a novel eryptotic pathway in red blood cells exposed to cigarette smoke, implicating p38 MAPK and Fas signaling—a pathway with potential relevance to vascular complications in smokers. This interest has evolved into a broader exploration of anti-eryptotic and anti-inflammatory properties of phytochemicals, including indicaxanthin and plant sterols, in models of oxidative stress and chronic disease. Dr. Restivo serves as Associate Editor for the Journal of Food Biochemistry, Review Editor for Frontiers in Cell and Developmental Biology and Frontiers in Molecular Biosciences, and participates in the Early Career Reviewer program of Journal of Biological Chemistry. A passionate advocate for science communication and collaboration, Dr. Restivo combines rigorous biochemical research with a strong commitment to mentorship and community building.

• Basic medicine

Dupe Ademola Popoola

Associate Editor, Ocular Oncology · 2026–present

University of Ilorin

Professor Dupe Ademola-Popoola is the Chairman and Head of the Department of Ophthalmology at the University of Ilorin and the University of Ilorin Teaching Hospital, Nigeria. A renowned Paediatric Ophthalmologist, she established the hospital’s Paediatric, Strabismus, and Pediatric Ocular Oncology Services. She holds Fellowships from the National Postgraduate Medical College of Nigeria and the West African College of Surgeons (2001), with subspecialty training in Paediatric Ophthalmology (LV Prasad Eye Institute, India) and Ophthalmic Oncology (Eye and Laser World Centre, Egypt). A champion for child eye health, Professor Ademola-Popoola has led innovative national responses to Retinopathy of Prematurity (ROP) and Retinoblastoma—from clinical care and research to policy and advocacy. She is a pioneer in task-shifting models, integrating ROP care into neonatal intensive care units (NICUs) by training and empowering NICU staff. She also initiated vision screening at immunization clinics by community health workers and developed the Teacher-LED Vision Screener (TELVIS)—a patented tool enabling early detection of vision problems in schools. Her work bridges clinical excellence, research, and health systems innovation. She has developed digital tools such as a web-searchable map of schools for children with special needs and advanced the use of telemedicine for equitable child eye care. Professor Ademola-Popoola is actively engaged in national and global leadership. She serves as a Global Advisor and Board Member of the American Academy of Ophthalmology. In recognition of her impactful work, she was named the 2025 Victor Anomah Ngu Distinguished Lecturer by the West African College of Surgeons and the Global Visiting Professor for the David Paton Lecture at Wills Eye Hospital, USA. Her efforts continue to transform paediatric eye care through advocacy, innovation, and inclusive system design—ensuring that children, even in the most underserved settings, receive timely, life-changing eye care

• Clinical medicine

Anton Lennikov, MD, PhD

Associate Editor, Vascular Biology · 2026–present

Schepens Eye Research Institute

Dr. Anton Lennikov is an Instructor in Ophthalmology at the Schepens Eye Research Institute, Harvard Medical School, and a biomedical scientist specializing in ocular pathology, retinal degeneration, and neuroinflammation. Trained as a physician in Russia and earning his Ph.D. in Medical Science from Hokkaido University in Japan, Dr. Lennikov has held research positions across premier institutions including Johns Hopkins, Linköping University, and the University of Missouri. His research centers on the role of retinal microglia in neurodegenerative diseases such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy, with a specific focus on how microglia contribute to pathological angiogenesis and retinal dysfunction. With over 50 peer-reviewed publications in journals such as Nature Biotechnology, FASEB Journal, Angiogenesis, Frontiers in Immunology, and Investigative Ophthalmology & Visual Science, Dr. Lennikov is widely recognized for his work on microglia-targeted therapies and electrical stimulation as a noninvasive strategy to preserve vision. His projects have received funding from the U.S. Army Medical Research and Development Command and the Massachusetts Lions Foundation, and he holds several patents, including innovations in neuroprotective compounds and therapeutic electrical stimulation protocols. His technical skills span immunohistochemistry, flow cytometry, Western blotting, cell signaling, and advanced in vivo and ex vivo models. Dr. Lennikov serves as Associate Editor for BMC Ophthalmology and Topic Editor for Frontiers in Immunology, and he actively reviews for more than 20 international journals. Fluent in Russian, English, and Japanese, he brings a global perspective to vision science. His long-term mission is to develop novel microglia-based therapies to improve outcomes for patients who do not respond to current anti-VEGF treatments, contributing to the broader goal of preventing blindness and enhancing quality of life worldwide.

• Biological sciences

Shaquria P. Adderley, PhD

Associate Editor, Vascular Biology · 2026–present

South Carolina School of Medicine

Dr. Shaquria P. Adderley is a Clinical Associate Professor at the University of South Carolina School of Medicine and a cardiovascular pharmacologist with extensive experience in physiology education and vascular biology research. She earned her Ph.D. in Pharmacology and Physiology from Saint Louis University, where her graduate work explored cellular signaling in erythrocytes, with a focus on red blood cell communication in the microcirculation and its implications for improving blood flow in diabetes. She later expanded her research to the cardiovascular system during her post-doctoral fellowships, studying vascular smooth muscle cell proliferation as it relates to stent restenosis, and eventually to lymphatic endothelial cell signaling and its role in endothelial barrier dysfunction and tissue edema. Dr. Adderley has conducted NIH- and institutionally funded research on the regulation of vascular permeability, the roles of phosphodiesterases and kinases in vascular tone and remodeling, and the impact of inflammatory mediators on lymphatic endothelial integrity. Dr. Adderley is a committed educator with over eight years of experience teaching physiology and pharmacology to medical, physician assistant, and health sciences students. She has served as a course director and instructor at institutions including Touro University Montana, Touro University Nevada, and the University of South Florida. Her teaching emphasizes active learning and clinical integration, and she has mentored undergraduate, graduate, and medical students in both classroom and laboratory settings. Dr. Adderley’s academic contributions include publications in Microcirculation, American Journal of Physiology – Heart and Circulatory Physiology, PLOS ONE, and Frontiers in Pharmacology, where she has also served as a Review Editor. She is an active member of professional societies such as the American Physiological Society, the International Association of Medical Science Educators, and ASPET. Her commitment to diversity and faculty development is evident through her leadership roles on curriculum and diversity committees.

• Biological sciences

Yushan Zhang, MD, PhD

Associate Editor, Vascular Biology · 2026–present

Cytovance Biologics

Dr. Yushan Zhang, MD, PhD, is a multidisciplinary biomedical scientist whose career bridges clinical medicine, academic research, and biopharmaceutical development. Initially trained and practicing as a physician in China, he transitioned to research to broaden his impact on patient care. Over a 15-year academic career in cancer biology, he investigated mechanisms of tumor angiogenesis, metastasis, and therapy resistance, with a strong emphasis on the tumor microenvironment and vascular biology. His work has resulted in over 30 publications, including contributions to Blood, Materials Today, Bioactive Materials, Circulation, and Science Translational Medicine. Currently serving as a Scientist in Downstream Process Development at Cytovance Biologics, Dr. Zhang leads projects involving protein purification, formulation, and process optimization for GMP production. He draws from both his academic insight and technical expertise to drive innovation in therapeutic protein manufacturing. His ability to connect molecular mechanisms to process design reflects a rare integration of fundamental and applied science. In addition to his scientific contributions, Dr. Zhang has mentored multiple students and associates, and served as a scientific editor and peer reviewer for multiple journals. His career demonstrates a sustained commitment to translational research. Read all his bibliography here.

• Biological sciences

Raghvendra Mall

Associate Editor, Big Data and Personalized Medicine · 2026–present

Technology Innovation Institute

Dr. Raghvendra Mall is a computational biologist and applied machine learning researcher at the Technology Innovation Institute, U.A.E, specializing in multi-omics data integration and advanced computational immunology. His expertise spans data sciences, systems biology, structural biology, and complex networks with a primary focus on developing innovative computational methods to extract meaningful biological insights from complex biomedical datasets. With a Ph.D. in Electrical Engineering and a robust portfolio of research grants, open-access codes, and patents, Dr. Mall has made significant contributions to biomedical research. He has been recognized as a Top 30 Early Career Professional by IEEE Computer Society and has led award-winning teams in challenging scientific competitions, including the Anti-PD1 Response Prediction DREAM Challenge. His work encompasses developing tools for therapeutic target identification, compound-viral protein interactions, and advanced machine learning applications in healthcare. Dr. Mall is a Section Editor for Medical Bioinformatics at the Journal of Translational Medicine and an Associate Editor for Frontiers in Big Data and Frontiers in Artificial Intelligence. His primary research interests include the role of PANoptosis in cancer, deep learning for protein property prediction (focusing on solubility, crystallization, and toxicity), and computational network biology involving differential network analysis, gene regulatory network reconstruction, and disease module identification in cellular networks. These research directions underscore his main commitment to translating computational innovations into meaningful biomedical advancements. Visit his personal website here.

• Computer and information sciences

Emanuele Alves

Associate Editor, Toxicology · 2026–present

University of South Wales

Dr. Emanuele Alves is currently a Senior Lecturer in Pharmacology and Toxicology at the University of South Wales and principal investigator of the Experimental Toxicology Research Laboratory (ETRL). Prior to that, she was Assistant Professor in Forensic Chemistry and Toxicology at Virginia Commonwealth University and Appalachian State University, and held positions at the Oswaldo Cruz Foundation, Brazil's National Board of Judicial Experts, and various universities in Brazil, Portugal, and Cape Verde. She holds a Ph.D. in Forensic Sciences from Porto University, Portugal, an M.Sc. in Chemistry from UFRJ, Brazil, a Postgraduate degree in Crime Scene Investigation from UCB, Brazil, a Degree in Pharmacy from UFF, Brazil, and a Technical degree in Biotechnology from the Federal Technical School of Chemistry, Brazil. Dr. Alves' research focuses on New Psychoactive Substances (NPSs) and homemade drugs, specifically the development and investigation of new pharmacologically active substances, alternative extraction and analytical methodologies for NPSs in "real-world" samples and biological tissues, natural poisons, mechanistic study of intoxications and antidote development, metabolomics, pharmacokinetics, and drug-drug interactions. Beyond her research publications, Dr. Alves has contributed to the scientific community through peer reviewing for various journals, serving on scientific society committees, and evaluating grant proposals including for the NSF Graduate Research Fellowship Program.

• Basic medicine

Vaibhav Sahni

Associate Editor, Plastic Surgery · 2026–present

All India Institute of Medical Sciences

Dr. Vaibhav Sahni is a scientist at the All India Institute of Medical Sciences (AIIMS), New Delhi, with dual specializations in Oral and Maxillofacial Surgery and Periodontics. He also holds the MFDS RCPS(Glasg), MFDS RCSEd, MFDS RCS(Eng) and the FDS RCS(Eng). His research focuses on maxillofacial injuries, point-of-care diagnostics, oral-systemic interactions, host-microbial interactions, and computational systems related to oral health and rehabilitation. Dr. Sahni's academic contributions include 75 PubMed-indexed publications, a long-standing experience as reviewer for several journals (being recognized as one of the top 2024 reviewers by Nature), and editorial positions in PLOS One, the European Journal of Medical Research, and the Journal of Medical Case Reports. He has invented and developed several free apps for clinicians, including MFTXAPP (calculators for FISS, MFISS, and GCS scores to help manage dental trauma), PerioPraX (for calculating periodontal and dental indices), and xGCS (a real-time Glasgow Coma Scale calculator). Beyond his research, Dr. Sahni is actively involved in community work. He served at the Blood Bank in Phagwara, Punjab, and led dental camps serving diverse communities including economically challenged, mentally challenged, differently-abled, and elderly patients. He expanded care at a Charitable Dispensary to include advanced dental and maxillofacial surgical procedures and participated in the Colgate Smile India Campaign, conducting dental screenings for thousands of students across multiple schools. Check all Dr. Sahni's articles on PubMed. Read more about his personal project: Research & Evidence (RF & E).

• Clinical medicine

Simon Lebech Cichosz, PhD

Associate Editor, Biomedical Engineering · 2026–present

Aalborg University

Dr. Simon Lebech Cichosz is an Associate Professor at Aalborg University. He pursued his PhD in Predictive Models in Diabetes and an M.Sc. in Biomedical Engineering. His research focuses on leveraging artificial intelligence and machine learning for improving diabetes diagnosis and treatment, with emphasis on developing personalized healthcare solutions. He serves as an editorial board member of the Journal of Diabetes Science and Technology and frequently acts as a peer reviewer for multiple journals in the fields of digital health and medical informatics. His research contributions include published datasets, conference papers, and articles in notable international and regional journals such as Computer Methods and Programs in Biomedicine, Diabetes Technology & Therapeutics, and Diabetes Care.

• Medical engineering

Balaji Krishnan, PhD

Associate Editor, Neurodegenerative Disorders of Aging · 2026–present

University of Texas Medical Branch

Dr. Balaji Krishnan, MSc in Molecular Biology/Physics (University of Mumbai) and PhD in Biology (University of Houston), is an Associate Professor at UTMB's Mitchell Center for Neurodegenerative Diseases. The Krishnan Lab is interested in understanding memory mechanisms, with a particular expertise on synaptic mechanisms in Alzheimer's and related dementias using electrophysiology, and behavior in Drosophila rodent models, and validation of molecular approaches in human clinical samples. His key contributions include adapting FASS-LTP for postmortem brain functional assays and discovering Phospholipase D's (PLD) role in health and disease. Dr. Krishnan's Alzheimer's research is funded by the Alzheimer's Association Research Grant as well as the National Institutes on Aging. He has served as an academic editor for Springer and Frontiers, and has a long-standing experience as reviewer for grants and papers in high-impact journals including Nature, Neuron, Journal of Neuroscience, and Journal of Neurophysiology.  His research on synaptic integrity in cognitively intact individuals with high Alzheimer's neuropathology received the 2021 Alzheimer Award, which recognizes the article published during the previous year that has had the most significant impact on Alzheimer’s disease research.

• Clinical medicine

Daniel O'Reilly, PhD, MRSC

Associate Editor, Neurodegenerative Disorders of Aging · 2026–present

University of Texas Medical Branch

Dr. Daniel O'Reilly, PhD in Chemistry from McGill University, is an Assistant Professor at the University of Texas Medical Branch in the Department of Pharmacology and Toxicology, where he leads research in oligonucleotide therapeutics. His lab is dedicated to advancing RNA-based therapeutics, focusing on innovative chemical modifications that enhance oligonucleotide stability, immune compatibility, and tissue-specific delivery. Dr. O'Reilly’s research aims to address rare and ultra-rare diseases, particularly Huntington's disease, and to develop targeted delivery solutions for tissues beyond the liver. Dr. O'Reilly has an extensive publication history, contributing to top journals like Nature Reviews Drug Discovery and Nucleic Acid Therapeutics. His work includes studies on chemical modifications of CRISPR systems for enhanced therapeutic efficacy, steric blocking in antisense oligonucleotides, and the use of di-valent siRNAs to inhibit repeat expansions in Huntington's disease models. His contributions to RNA chemistry and therapeutic development reflect his commitment to translating scientific advances into clinical solutions, particularly for underserved patient populations.

• Clinical medicine

Said Arévalo Alquichire, PhD

Associate Editor, Biomedical Engineering · 2026–present

Schepens Eye Research Institute of Mass Eye & Ear

Said Arévalo-Alquichire is a Chemical Engineer and a PhD in Biosciences from Universidad de la Sabana (Colombia). Currently, he is a Research Fellow at the Schepens Eye Research Institute of Mass Eye & Ear and the Department of Ophthalmology at Harvard Medical School. Over the past nine years, he has dedicated his research to the development of novel elastomeric materials, focusing on designing bioactive polymers for diverse applications such as vascular grafts, coatings, and biostable biomaterials. His work extends to translational research, where he has pioneered novel therapies for various vascular pathologies and ocular diseases. These include proliferative diabetic retinopathy, macular degeneration, proliferative vitreoretinopathy, as well as innovative approaches to addressing dementia.

• Medical engineering

Salvador Pastor Idoate, PhD

Associate Editor, Clinical Ophthalmology · 2026–present

University of Valladolid

Dr. Salvador Pastor Idoate is a specialist in retina and vitreous diseases. He is currently an Associate Professor of Ophthalmology at the University of Valladolid and the medical director of IOBA (Instituto Universitario de Oftalmología Aplicada). His extensive training includes a PhD in Visual Sciences, a fellowship in Medical Retina at the Manchester Royal Eye Hospital and a vitreoretinal surgery fellowship at Vall d'Hebron Hospital in Barcelona. Dr. Pastor Idoate's research primarily focuses on diabetic retinopathy, proliferative vitreoretinopathy, retinal detachment, age-related macular degeneration and retinal dystrophies. He is dedicated to identifying molecular and genetic biomarkers for retinal diseases and advancing new technologies for retinal surgery. His clinical work emphasizes medical and surgical retina care, particularly in complex conditions like proliferative vitreoretinopathy and retinal detachments. He has been the principal investigator in four national clinical research projects and collaborated in over twenty clinical trials. Dr. Pastor Idoate has 47 indexed publications and numerous presentations at national and international conferences​.

• Clinical medicine

Mahmoud Ramadan Ramadan, PhD

Associate Editor, Pharmacology · 2026–present

Mansoura University

Dr. Mahmoud Ramadan Ramadan is a distinguished Associate Professor of Cardiology at the Faculty of Medicine, Mansoura University, a position he has held since 2018. Prior to his current role, he served as a Lecturer of Cardiology at the same institution from 2010-2018. He earned his PhD in Cardiology from the First Department of Internal Medicine at Niigata University, Japan, where he also received a license for Advanced Clinical Training by the Japanese Ministry of Health, Labor, and Welfare. Dr. Ramadan’s clinical foundation was built during his tenure as a Resident of Cardiology at Mansoura University Hospitals and Mansoura Emergency Hospital, including the Coronary Care Unit, from October 1997 to June 2001. He initially started his medical career as a Primary Health Care Physician within the Egyptian Ministry of Health and as a House Officer in Mansoura University Hospitals. He has published +40 articles in prestigious international and regional journals, such as The Lancet and the NEJM.

• Basic medicine

Ana Isabel Salazar Puerta, PhD

Associate Editor, Biomedical Engineering · 2026–present

The Ohio State University

Ana Isabel Salazar Puerta is a Postdoctoral Fellow, with a PhD in biomedical engineering from The Ohio State University, following her bachelor’s degree in biomedical engineering from Universidad EIA in Colombia. Her research is centered on developing micro/nanotechnology-based systems for gene delivery and cell therapies, with the goal of engineering cells and tissues to enhance tissue regeneration. Dr. Salazar Puerta has leveraged these systems to generate therapeutic extracellular vesicles (EVs) for treating various medical conditions (e.g., pulmonary inflammation, low back pain, diabetes, and cancer), and has used these platforms to induce controlled lineage conversions in vivo to enhance the rate of peripheral nerve regeneration. She has published extensively in multiple journals, holds several patent applications, has presented her work at several national/international conferences, and frequently serves as a technical reviewer for various journals.

• Medical engineering

Mustafa Sami, PhD

Associate Editor, Pharmacology · 2026–present

Okinawa Institute of Science and Technology

Dr. Mustafa Sami, a researcher at the Okinawa Institute of Science and Technology (OIST), brings a wealth of expertise to his work. With a strong foundation from institutions like the RIKEN Center for Biosystems Dynamics Research, Dr. Sami’s multidisciplinary skills cover a wide spectrum. Signal Processing: Dr. Sami excels in analyzing and manipulating signals, a crucial aspect in various scientific domains. Digital Image Processing: His proficiency extends to processing and enhancing digital images, a vital tool in fields like microscopy and medical imaging. Complex Network Analysis: Dr. Sami investigates intricate networks, uncovering patterns and connections within complex systems. Deep Learning: He harnesses the power of neural networks to solve intricate problems, particularly in image analysis and pattern recognition. Quantitative Biology: Dr. Sami’s work bridges biology and mathematics, quantifying biological phenomena through rigorous analysis. Automated Image Processing and Analysis: He has spearheaded projects developing software for automated image processing and analysis in cell and developmental biology. Dr. Sami’s dedication to computational biology and medical image processing underscores his significant impact on scientific research. His work not only advances our understanding of biological processes but also contributes to cutting-edge technologies. His work has been published in reputable journals such as Nature Cell Biology, Developmental Cell, and Scientific Reports.

• Basic medicine

Jorge Ruiz Medrano, PhD

Associate Editor, Clinical Ophthalmology · 2026–present

Puerta de Hierro University

Dr. Jorge Ruiz Medrano is a vitreo-retinal specialist currently associated with the Ocular Microsurgery Institute (IMO) Grupo Miranza in Madrid and the Puerta de Hierro University Hospital. He completed his Ophthalmology training at the Clinico San Carlos University Hospital and earned his PhD with the highest honors, Summa Cum Laude, from Complutense University of Madrid, where he was awarded the Extraordinary Doctoral Thesis Award. His clinical expertise includes the medical and surgical management of retinal and macular pathologies such as retinal detachment, age-related macular degeneration, diabetic retinopathy, and conditions associated with high myopia, alongside cataract surgery. As part of his extensive training, he completed two international Fellowships for his subspecialization in surgical retina and ocular oncology at the Jules-Gonin Hospital in Lausanne and the Bellvitge University Hospital. Dr. Ruiz Medrano is the author of over 40 international scientific papers and 28 book chapters, and has contributed to more than 20 international clinical trials. In 2016, he was awarded the title of Fellow of the European Board of Ophthalmology in Paris.

• Clinical medicine

Santiago Delgado Tirado, MD

Associate Editor, Clinical Ophthalmology · 2026–present

Miranza

Dr. Santiago Delgado Tirado specializes in cornea, cataract, and refractive surgery. He holds an MD and MSc in Vision Research from the University of Valladolid, where he also completed his residency in Ophthalmology at the Clinic Hospital of Valladolid. Dr. Delgado is currently pursuing a PhD in Medicine from the Universidad Autónoma de Madrid. His extensive education includes a research fellowship at the Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, where he has also served as a research consultant. Currently, Dr. Delgado is an Ophthalmology Specialist at Miranza. His research expertise is centered on aberrant angiogenesis and ocular fibrosis. His significant contributions to the field have been recognized with several awards, including the Medical Research in Retina Award and the Best Scientific Paper Award from Schepens Eye Research Institute. Dr. Delgado Tirado is also an active member of key ophthalmological societies such as SECOIR, ESCRS, and ASCRS, and has presented his findings at numerous international conferences.

• Clinical medicine

Andrés F. Salazar Gómez, PhD

Associate Editor, Biomedical Engineering · 2026–present

MIT Open Learning

Andrés Felipe Salazar Gómez, biomedical engineer and PhD in Computational Neuroscience, is a research scientist at MIT Open Learning where he works in the intersection of neuroscience and education. His research is focused on studying novel pedagogical and technological approaches to promote learning, researching brain-computer interfaces for human-robot interaction, capturing and quantifying tacit knowledge and expertise to understand implicit learning, using AR/VR systems for improving training, and exploring science policy in the domain of education. Andrés has 10+ years of expertise in experimental design, data science and quantitative methods and advocates data-driven insights to enhance educational research and assessment towards accessible high-quality education, for everyone, everywhere. He is an experienced published author and reviewer for several academic journals.

• Medical engineering

Ana Elisa Casas Botero, PhD

Associate Editor, Biomedical Engineering · 2026–present

A&T Bionano

Ana Elisa Casas Botero is a chemical engineer, master in biotechnology, and doctor in materials science. She was associated with the Pontifical Bolivarian University of Colombia for 20 years, where she worked as a professor, researcher, and director of the Chemical Engineering Faculty for the Textile Engineering and Nanotechnology programs. Ana Elisa has published various scientific articles on biotechnology and materials topics and has worked as a co-investigator in projects related to the treatment and diagnosis of colon cancer using bio and nanobiotechnology. She has more than 50 publications, 2 patents, and over 20 technical innovations. Her work includes protocols for determining various chemical substances in wastewater and agricultural residues, the development of biosynthetic methods for producing nanomaterials, and innovations in biotechnology. Notable projects she has supervised include studies on the adsorption and flotation of ferronickel extraction residues using bacteria, and the production of enzymes from sugarcane bagasse. Additionally, Ana Elisa has made significant contributions to cancer research, particularly in developing nanotechnological approaches for the targeted treatment of colon cancer. She currently works as a businesswoman and co-founder of A&T Bionano, a Colombian tech-based company focused on the production of environmentally friendly nanotechnological compounds for various agro-industrial and food applications.  Check her research on NanoBioCancer here.

• Medical engineering

Daisy Y. Shu, PhD

Associate Editor, Translational Ophthalmology and Visual Science · 2026–present

UNSW, Sydney

Dr. Daisy Shu is a Senior Lecturer and Head of the Retinal Research Group at the University of New South Wales' School of Optometry and Vision Science. Holding a Bachelor of Optometry and Vision Science from UNSW (2013) and a PhD in Cellular and Molecular Biology from the University of Sydney (2019), she further advanced her expertise through postdoctoral research at Harvard Medical School's Schepens Eye Research Institute. An expert in retinal epithelial and endothelial cell biology, Dr. Shu’s research delves into mitochondrial and metabolic dysfunctions that drive retinal diseases like age-related macular degeneration (AMD). Her work on the molecular mechanisms of epithelial-mesenchymal transition has provided critical insights into AMD pathogenesis and potential therapeutic targets, and has been supported by prestigious grants and awards, including the ARVO Emerging Advocate Award and the ASIP Postdoctoral Award for Outstanding Research. Beyond her research, she is dedicated to translating scientific discoveries into clinical trials aimed at curing AMD, actively engages in science communication through her podcast “Behind Our Science,” and leads educational initiatives for graduate students.

• Clinical medicine